- Home
- DIT vs IMUX Comparison
DIT vs IMUX Comparison
Compare DIT & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIT
- IMUX
- Stock Information
- Founded
- DIT 1981
- IMUX 2016
- Country
- DIT United States
- IMUX United States
- Employees
- DIT N/A
- IMUX N/A
- Industry
- DIT Food Distributors
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- DIT Consumer Discretionary
- IMUX Health Care
- Exchange
- DIT Nasdaq
- IMUX Nasdaq
- Market Cap
- DIT 78.7M
- IMUX 67.8M
- IPO Year
- DIT 1995
- IMUX N/A
- Fundamental
- Price
- DIT $115.50
- IMUX $0.73
- Analyst Decision
- DIT
- IMUX Strong Buy
- Analyst Count
- DIT 0
- IMUX 6
- Target Price
- DIT N/A
- IMUX $11.60
- AVG Volume (30 Days)
- DIT 590.0
- IMUX 2.5M
- Earning Date
- DIT 07-17-2025
- IMUX 08-07-2025
- Dividend Yield
- DIT 0.87%
- IMUX N/A
- EPS Growth
- DIT N/A
- IMUX N/A
- EPS
- DIT 2.44
- IMUX N/A
- Revenue
- DIT $2,221,421,072.00
- IMUX N/A
- Revenue This Year
- DIT N/A
- IMUX N/A
- Revenue Next Year
- DIT N/A
- IMUX N/A
- P/E Ratio
- DIT $47.39
- IMUX N/A
- Revenue Growth
- DIT 7.47
- IMUX N/A
- 52 Week Low
- DIT $94.92
- IMUX $0.56
- 52 Week High
- DIT $166.00
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- DIT 57.52
- IMUX 41.51
- Support Level
- DIT $100.08
- IMUX $0.68
- Resistance Level
- DIT $115.00
- IMUX $0.74
- Average True Range (ATR)
- DIT 5.01
- IMUX 0.06
- MACD
- DIT 1.78
- IMUX 0.00
- Stochastic Oscillator
- DIT 94.25
- IMUX 27.32
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.